|
of diabetes, especially type 2 diabetes, and it is
the leading cause of death from diabetes.� Doctors know that diabetogenic ischemia (constriction of blood vessels)
can progress undetected for years before obvious symptoms (angina, heart attack) occur.� Quick and timely intervention saves lives. ���� The problem
has been to detect diabetic heart disease in its early stages, before the obvious symptoms manifest and major damage is done. ���� Yale University
and DuPont Pharmaceuticals announce the ���� The study
is expected to take three years.�
The researchers are seeking 1000 adult type 2 diabetics
who have exhibiting clinical signs of heart disease.� If you meet the conditions, and are interested in volunteering, please contact the nearest center and individual named below: ���� Yale University�
(New Haven, CT) Janice Davey MSN, APRN, Study Coordinator; telephone:
(203) ���� Norwalk
Hospital/Soundview Research Associates (Norwalk, CT) Gin Hoenig, RN, Nurse Coordinator; telephone: (203)
838‑ 4000, ext. 205 ���� University
of Alabama� (Birmingham,
AL) Dare Hartsell, RN, BSN, Nurse Coordinator; telephone:
(205) 934‑0821 ���� Tulane
University (New Orleans, LA) Vivian Fonseca, MD, Tulane Alumni Chair in Diabetes; telephone: (504) 585‑4026 ���� University
of Chicago (Chicago, IL) Maureen McCormick, RN, Nurse Coordinator; telephone:
(773) 702‑0204 ���� University
of Rochester (Rochester, NY) Mary Kelly, RN, Nurse Coordinator; telephone: (716)
273‑4072 ���� University
of Virginia (Charlottesville, VA) Wendie Price, RN, Nurse Coordinator; telephone: (804)
924‑ 5869 |
||
����������������������������
���������������